← FDA DRUG APPROVALS

FDA ANDA · ANDA085167

PROCAINAMIDE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA085167
TYPE
ANDA
ORIGINAL APPROVAL
1980-07-17
LATEST ACTION
1991-12-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 250MG · CAPSULE · ORAL

Approval history

1991-12-09Labeling · Supplement 23AP
1991-04-26Labeling · Supplement 22AP
1988-11-29Labeling · Supplement 20AP
1988-08-12Labeling · Supplement 18AP
1980-07-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →